Cargando…
Do Additional Clinical Risk Factors Improve the Performance of Fracture Risk Assessment Tool (FRAX) Among Postmenopausal Women? Findings From the Women's Health Initiative Observational Study and Clinical Trials
The ability of the fracture risk assessment tool (FRAX) to discriminate between women who do and do not experience major osteoporotic fractures (MOFs) is suboptimal. Adding common clinical risk factors may improve discrimination. We used data from the Women's Health Initiative, a prospective st...
Autores principales: | Crandall, Carolyn J, Larson, Joseph, Cauley, Jane A, Schousboe, John T, LaCroix, Andrea Z, Robbins, John A, Watts, Nelson B, Ensrud, Kristine E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894725/ https://www.ncbi.nlm.nih.gov/pubmed/31844827 http://dx.doi.org/10.1002/jbm4.10239 |
Ejemplares similares
-
Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal: Secondary Analysis of a Randomized Clinical Trial
por: Mitchell, Caroline M., et al.
Publicado: (2022) -
Association of Physical Activity and Fracture Risk Among Postmenopausal Women
por: LaMonte, Michael J., et al.
Publicado: (2019) -
After the initial fracture in postmenopausal women, where do subsequent fractures occur?
por: Crandall, Carolyn J., et al.
Publicado: (2021) -
Urinary phytate concentration and risk of fracture determined by the FRAX index in a group of postmenopausal women
por: LOPEZ-GONZALEZ, ANGEL A., et al.
Publicado: (2019) -
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)